dihydroergotoxine and Brain-Damage--Chronic

dihydroergotoxine has been researched along with Brain-Damage--Chronic* in 3 studies

Trials

1 trial(s) available for dihydroergotoxine and Brain-Damage--Chronic

Article	Year
[Efficacy of the combination drug vasobral in chronic vascular encephalopathy]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2014, Volume: 114, Issue:10 Despite the high prevalence of chronic vascular encephalopathy, its diagnosis and treatment remain understudied. This observational multicenter trial assessed the efficacy and safety of vasobral in patients with cerebral ischemia.. The open observational study was carried out in 37 centers in 11 Russian cities and included 300 patients with confirmed diagnosis of chronic vascular encephalopathy, stages 1 and 2, without dementia. The patients received 1 tablet (4 mg α-dihydroergocryptine and 40 mg caffeine) 2 times a day during 3 months.. There was an improvement of cognitive and affective status as well as quality of life and a decrease of subjective signs of chronic vascular encephalopathy. Vasobral did not cause significant fluctuations of arterial pressure and was safe for patients with chronic vascular encephalopathy and arterial hypertension. Topics: Adult; Aged; Brain Damage, Chronic; Brain Ischemia; Caffeine; Cerebral Small Vessel Diseases; Dihydroergotoxine; Drug Combinations; Female; Humans; Male; Middle Aged; Treatment Outcome	2014

Article

Year

[Efficacy of the combination drug vasobral in chronic vascular encephalopathy].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2014, Volume: 114, Issue:10

Despite the high prevalence of chronic vascular encephalopathy, its diagnosis and treatment remain understudied. This observational multicenter trial assessed the efficacy and safety of vasobral in patients with cerebral ischemia.. The open observational study was carried out in 37 centers in 11 Russian cities and included 300 patients with confirmed diagnosis of chronic vascular encephalopathy, stages 1 and 2, without dementia. The patients received 1 tablet (4 mg α-dihydroergocryptine and 40 mg caffeine) 2 times a day during 3 months.. There was an improvement of cognitive and affective status as well as quality of life and a decrease of subjective signs of chronic vascular encephalopathy. Vasobral did not cause significant fluctuations of arterial pressure and was safe for patients with chronic vascular encephalopathy and arterial hypertension.

Topics: Adult; Aged; Brain Damage, Chronic; Brain Ischemia; Caffeine; Cerebral Small Vessel Diseases; Dihydroergotoxine; Drug Combinations; Female; Humans; Male; Middle Aged; Treatment Outcome

2014

Other Studies

2 other study(ies) available for dihydroergotoxine and Brain-Damage--Chronic

Article	Year
[Psychopharmaca in the aged]. Nederlands tijdschrift voor geneeskunde, 1977, Mar-26, Volume: 121, Issue:13 Topics: Aged; Brain Damage, Chronic; Dementia; Dihydroergotoxine; Humans; Intracranial Arteriosclerosis; Mental Disorders; Monoamine Oxidase Inhibitors; Procainamide; Psychotropic Drugs; Tranquilizing Agents	1977
The use of psychoactive drugs in elderly patients with psychiatric disorders: survey conducted in twelve Veterans Administration hospitals. Journal of the American Geriatrics Society, 1975, Volume: 23, Issue:3 A survey conducted at 12 VA hospitals included the collection of detailed information on the use of psychoactive drugs in 1,276 elderly psychiatric patients. On the day of the survey, 61 per cent of the patients were receiving psychoactive drugs. Prescription practices relating to the choice of drugs, prevalence of drug use, dosage, combination drug preparations, and antiparkinson agents are discussed in terms of such factors as the patient's age and the diagnosis. Also discussed is the literature on psychoactive drugs, particularly as it pertains to elderly populations. Topics: Aged; Anti-Anxiety Agents; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Anxiety; Benzodiazepines; Brain; Brain Damage, Chronic; Dementia; Dihydroergotoxine; Drug Therapy, Combination; Ergoloid Mesylates; Female; Health Surveys; Hospital Units; Hospitals, Veterans; Humans; Male; Mental Disorders; Phenothiazines; Schizophrenia; United States; Vasodilator Agents	1975

Article

Year

[Psychopharmaca in the aged].

Nederlands tijdschrift voor geneeskunde, 1977, Mar-26, Volume: 121, Issue:13

Topics: Aged; Brain Damage, Chronic; Dementia; Dihydroergotoxine; Humans; Intracranial Arteriosclerosis; Mental Disorders; Monoamine Oxidase Inhibitors; Procainamide; Psychotropic Drugs; Tranquilizing Agents

1977

The use of psychoactive drugs in elderly patients with psychiatric disorders: survey conducted in twelve Veterans Administration hospitals.

Journal of the American Geriatrics Society, 1975, Volume: 23, Issue:3

A survey conducted at 12 VA hospitals included the collection of detailed information on the use of psychoactive drugs in 1,276 elderly psychiatric patients. On the day of the survey, 61 per cent of the patients were receiving psychoactive drugs. Prescription practices relating to the choice of drugs, prevalence of drug use, dosage, combination drug preparations, and antiparkinson agents are discussed in terms of such factors as the patient's age and the diagnosis. Also discussed is the literature on psychoactive drugs, particularly as it pertains to elderly populations.

Topics: Aged; Anti-Anxiety Agents; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Anxiety; Benzodiazepines; Brain; Brain Damage, Chronic; Dementia; Dihydroergotoxine; Drug Therapy, Combination; Ergoloid Mesylates; Female; Health Surveys; Hospital Units; Hospitals, Veterans; Humans; Male; Mental Disorders; Phenothiazines; Schizophrenia; United States; Vasodilator Agents

1975